• 1. Evolution of calcium phosphate precipitation in hanging drop vapor diffusion by in situRaman microspectroscopy
  Gloria Belén Ramírez-Rodríguez,José Manuel Delgado-López,Jaime Gómez-Morales CrystEngComm, 2013,15, 2206-2212
• 2. Emulsion technologies for multicellular tumour spheroid radiation assays?
  Kay S. McMillan,Anthony G. McCluskey,Annette Sorensen,Marie Boyd,Michele Zagnoni Analyst, 2016,141, 100-110
• 3. Emerging investigator series: first-principles and thermodynamics comparison of compositionally-tuned delafossites: cation release from the (001) surface of complex metal oxides?
  Joseph W. Bennett,Diamond T. Jones,Blake G. Hudson,Joshua Melendez-Rivera,Robert J. Hamers,Sara E. Mason Environ. Sci.: Nano, 2020,7, 1642-1651
• 4. Emerging enantiomeric resolution materials with homochiral nano-fabrications
  Ji-Ping Wei Nanoscale, 2015,7, 11815-11832
• 5. Excitation energies from ground-state density-functionals by means of generator coordinates
  A. B. F. da Silva,K. Capelle Phys. Chem. Chem. Phys., 2009,11, 4564-4569

Comprehensive Overview of 3-Pyrrolidinecarboxylic acid, 4-cyclopropyl-, 1,1-dimethylethyl ester (CAS No. 2167561-87-5)

The compound 3-Pyrrolidinecarboxylic acid, 4-cyclopropyl-, 1,1-dimethylethyl ester (CAS No. 2167561-87-5) is a specialized organic molecule with significant potential in pharmaceutical and agrochemical research. Its unique structure, featuring a pyrrolidine core substituted with a cyclopropyl group and protected by a tert-butyl ester, makes it a valuable intermediate in synthetic chemistry. Researchers and industry professionals are increasingly interested in this compound due to its versatility in drug discovery and its role in modulating biological activity.

In recent years, the demand for pyrrolidine derivatives has surged, driven by their applications in designing protease inhibitors, receptor modulators, and other bioactive molecules. The 4-cyclopropyl substitution in this compound enhances its steric and electronic properties, which can influence binding affinity and metabolic stability. This aligns with current trends in medicinal chemistry, where fine-tuning molecular scaffolds is critical for optimizing drug candidates. Searches for "pyrrolidine-based building blocks" and "cyclopropyl-modified esters" have spiked, reflecting the growing interest in such compounds.

The tert-butyl ester group in CAS No. 2167561-87-5 serves as a protective moiety, enabling selective deprotection during multi-step syntheses. This feature is particularly valuable in peptide mimetics and fragment-based drug design, where controlled reactivity is essential. Laboratories focusing on "protecting group strategies" or "ester hydrolysis optimization" often explore derivatives like this for their synthetic flexibility. Additionally, the compound's stability under various conditions makes it suitable for high-throughput screening and combinatorial chemistry.

From an industrial perspective, 3-Pyrrolidinecarboxylic acid, 4-cyclopropyl-, 1,1-dimethylethyl ester is gaining attention for its scalability and compatibility with green chemistry principles. Manufacturers are investigating solvent-free reactions and catalytic methods to produce such intermediates sustainably. Queries like "eco-friendly synthesis of pyrrolidine esters" and "cost-effective chiral intermediates" highlight the market's focus on efficiency and environmental impact. This compound's potential extends to agrochemicals, where its structural motifs may contribute to novel herbicides or growth regulators.

Analytical characterization of CAS No. 2167561-87-5 typically involves advanced techniques such as NMR, HPLC-MS, and X-ray crystallography to confirm purity and stereochemistry. The rise of "structure-activity relationship (SAR) studies" and "computational modeling of small molecules" underscores the need for well-defined intermediates like this. Its spectral data and physicochemical properties are crucial for researchers validating synthetic routes or designing analogs with improved pharmacokinetic profiles.

In summary, 3-Pyrrolidinecarboxylic acid, 4-cyclopropyl-, 1,1-dimethylethyl ester represents a convergence of synthetic utility and biological relevance. Its applications span early-stage drug development to process chemistry, addressing contemporary challenges in molecular design. As interest in "tailored heterocyclic compounds" and "next-generation pharmaceutical intermediates" grows, this compound is poised to play a pivotal role in advancing chemical innovation.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)